JP2019501631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501631A5 JP2019501631A5 JP2018521289A JP2018521289A JP2019501631A5 JP 2019501631 A5 JP2019501631 A5 JP 2019501631A5 JP 2018521289 A JP2018521289 A JP 2018521289A JP 2018521289 A JP2018521289 A JP 2018521289A JP 2019501631 A5 JP2019501631 A5 JP 2019501631A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- receptor agonist
- agonist protein
- gitr receptor
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245815P | 2015-10-23 | 2015-10-23 | |
| US62/245,815 | 2015-10-23 | ||
| PCT/EP2016/075552 WO2017068185A1 (en) | 2015-10-23 | 2016-10-24 | Single-chain gitr-receptor agonist proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501631A JP2019501631A (ja) | 2019-01-24 |
| JP2019501631A5 true JP2019501631A5 (enExample) | 2019-12-05 |
| JP6959229B2 JP6959229B2 (ja) | 2021-11-02 |
Family
ID=57241058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521289A Expired - Fee Related JP6959229B2 (ja) | 2015-10-23 | 2016-10-24 | 一本鎖ｇｉｔｒ受容体アゴニストタンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10533043B2 (enExample) |
| EP (1) | EP3365363A1 (enExample) |
| JP (1) | JP6959229B2 (enExample) |
| CN (1) | CN108473549A (enExample) |
| AU (1) | AU2016341402B2 (enExample) |
| CA (1) | CA3002741A1 (enExample) |
| WO (1) | WO2017068185A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41460A (fr) | 2015-02-03 | 2017-12-12 | Oncomed Pharm Inc | Agents de liaison à la tnfrsf et leurs utilisations |
| CN110869392A (zh) | 2017-05-16 | 2020-03-06 | 百时美施贵宝公司 | 用抗gitr激动性抗体治疗癌症 |
| CN115836084A (zh) | 2020-05-15 | 2023-03-21 | 阿珀吉尼科斯股份公司 | 多特异性免疫调节剂 |
| WO2023088876A1 (en) | 2021-11-16 | 2023-05-25 | Apogenix Ag | Multi-specific immune modulators |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69933216T2 (de) * | 1998-06-15 | 2007-09-20 | GTC Biotherapeutics, Inc., Framingham | Erythropoietin-analog-menschliches serum-albumin fusionsprotein |
| ATE462725T1 (de) * | 1998-08-25 | 2010-04-15 | Merck Patent Gmbh | Expression und export von angiostatin und endostatin als immunofusins |
| AR025984A1 (es) | 1999-10-07 | 2002-12-26 | Maxygen Aps | Polipeptidos oligomericos de cadena simple |
| DE19963859A1 (de) | 1999-12-30 | 2001-07-12 | Apotech Res & Dev Ltd | Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen |
| CA2314199A1 (en) | 2000-07-21 | 2002-01-21 | Robert Simoneau | C-chip |
| DE10122140A1 (de) * | 2001-05-08 | 2002-11-28 | Apotech Res & Dev Ltd | Rekombinante Fusionsproteine und deren Trimere |
| DE102004014983A1 (de) * | 2004-03-26 | 2005-10-20 | Univ Stuttgart | Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung |
| EP1746161A1 (en) | 2005-07-20 | 2007-01-24 | Cytheris | Glycosylated IL-7, preparation and uses |
| EP2005185B1 (en) * | 2006-03-22 | 2010-10-20 | Viral Logic Systems Technology Corp. | Methods for identifying polypeptide targets |
| JP5283104B2 (ja) * | 2007-01-10 | 2013-09-04 | 独立行政法人理化学研究所 | アセチル化及び脱アセチル化の蛍光可視化検出方法 |
| JP2010518140A (ja) * | 2007-02-14 | 2010-05-27 | グラクソ グループ リミテッド | Ｉｇｆ−１ｒに対する新規抗体 |
| ES2657801T3 (es) | 2007-07-10 | 2018-03-06 | Apogenix Ag | Proteínas de fusión de colectina de la superfamilia de TNF |
| AU2008281801A1 (en) * | 2007-08-01 | 2009-02-05 | Glaxo Group Limited | Novel antibodies |
| EP3002299A1 (en) | 2008-06-03 | 2016-04-06 | AbbVie Inc. | Dual variable domain immunoglobulins and uses thereof |
| EP3103875A1 (en) * | 2008-07-21 | 2016-12-14 | Apogenix AG | Tnfsf single chain molecules |
| ES2593049T3 (es) | 2009-01-09 | 2016-12-05 | Apogenix Ag | Proteínas de fusión que forman trímeros |
| US8637637B2 (en) * | 2010-01-12 | 2014-01-28 | Bill Nai-Chau Sun | Fc fusion proteins of human growth hormone |
| CN102250250A (zh) * | 2011-07-09 | 2011-11-23 | 浙江大学 | 一种人鼠嵌合型抗人CD19抗体Hm2E8b及用途 |
| AU2012356894B2 (en) * | 2011-12-23 | 2018-01-18 | Araris Biotech Ltd. | Enzymatic conjugation of polypeptides |
| NO2776305T3 (enExample) * | 2014-04-23 | 2018-01-27 | ||
| JP2014218510A (ja) * | 2014-08-11 | 2014-11-20 | アポゲニクスゲゼルシャフト ミット ベシュレンクテルハフツングＡｐｏｇｅｎｉｘ ＧｍｂＨ | 三量体形成融合タンパク質 |
-
2016
- 2016-10-24 EP EP16791342.5A patent/EP3365363A1/en not_active Withdrawn
- 2016-10-24 CA CA3002741A patent/CA3002741A1/en not_active Abandoned
- 2016-10-24 WO PCT/EP2016/075552 patent/WO2017068185A1/en not_active Ceased
- 2016-10-24 CN CN201680073664.8A patent/CN108473549A/zh active Pending
- 2016-10-24 AU AU2016341402A patent/AU2016341402B2/en not_active Ceased
- 2016-10-24 JP JP2018521289A patent/JP6959229B2/ja not_active Expired - Fee Related
-
2018
- 2018-04-19 US US15/957,279 patent/US10533043B2/en active Active
-
2020
- 2020-01-02 US US16/732,854 patent/US11149075B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500850A5 (enExample) | ||
| RU2017141727A (ru) | Одноцепочечные белки-агонисты рецептора cd40 | |
| JP2018533947A5 (enExample) | ||
| CN103380143B (zh) | 结合il-23的基于纤连蛋白的支架结构域蛋白质 | |
| JP2018533948A5 (enExample) | ||
| DK2855509T3 (en) | NON-NATURAL CONSENSUS ALBUMIN BINDING DOMAINS | |
| US8927693B2 (en) | Fibronectin based scaffold domain proteins that bind IL-23 | |
| JP7121496B2 (ja) | 癌治療で使用するためのペグ化インターロイキン－１０ | |
| US20240100129A1 (en) | Serum Albumin-Binding Fibronectin Type III Domains | |
| RU2015110250A (ru) | ВАРИАНТЫ FcγRIIB-СПЕЦИФИЧЕСКОЙ Fc-ОБЛАСТИ | |
| CA2908208A1 (en) | Interleukin-10 compositions and uses thereof | |
| EP2569326B1 (en) | Peptide-based inhibitor of interleukin-10 or stat-3 activation | |
| AU2015369808A1 (en) | Methods of improving yield in recombinant protein production | |
| US20230100941A1 (en) | Molecules targeting mutant ras protein | |
| EP2597102A1 (en) | A novel fusion protein comprising an antibody light chain and a polypeptide binding to IL-17 | |
| US10464983B2 (en) | Variants of adrenomedullin and calcitonin gene-related peptide and methods of use | |
| Mishra et al. | Molecular fingerprints of a convergent mechanism orchestrating diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptors | |
| Peña et al. | Synthesis and biological properties of chimeric interferon-α2b peptides | |
| Becker et al. | Eva Johansson1, Jakob Lerche Hansen1, Ann Maria Kruse Hansen1, Allan Christian Shaw1 | |
| HK40006036A (en) | Serum albumin-binding fibronectin type iii domains | |
| NZ741439B2 (en) | Dual function proteins and pharmaceutical composition comprising same | |
| NZ741431B2 (en) | Long-acting fgf21 fusion proteins and pharmaceutical composition comprising same | |
| NZ741431A (en) | Long-acting fgf21 fusion proteins and pharmaceutical composition comprising same |